Penile cancer is a rare disease. Most of penile cancer are squamous cell carcinoma. Diagnosis is based on self-examination, clinical examination and confirmatory biopsy. Several imaging techniques could be used for staging purposes. However, the best modality for staging in intermediate and high-risk patients is by surgical evaluation and the use of inguinal lymph node dissection, that has also a therapeutic effect. Unfortunately, inguinal lymph node dissection is underused. Penile cancer treatment may have a major adverse impact on urinary and sexual function and on quality of life. Penile-sparing surgery and radiation therapies are available, and in selected patients offer good outcomes with acceptable rates of local recurrence. Penile-sparing surgery should be preferred when indicated. Follow-up with periodical controls is mandatory up to 5 years. However, risk of local, nodal and distant recurrence after 5 years was reported. Imaging is not routinely recommended during follow-up. Patients should be trained to self-examination during the follow-up.

New insight in penile cancer / Marchioni, M.; Berardinelli, F.; De Nunzio, C.; Spiess, P.; Porpiglia, F.; Schips, L.; Cindolo, L.. - In: MINERVA UROLOGICA E NEFROLOGICA. - ISSN 0393-2249. - 70:6(2018), pp. 559-569. [10.23736/S0393-2249.18.03215-0]

New insight in penile cancer

Marchioni M.;De Nunzio C.;
2018

Abstract

Penile cancer is a rare disease. Most of penile cancer are squamous cell carcinoma. Diagnosis is based on self-examination, clinical examination and confirmatory biopsy. Several imaging techniques could be used for staging purposes. However, the best modality for staging in intermediate and high-risk patients is by surgical evaluation and the use of inguinal lymph node dissection, that has also a therapeutic effect. Unfortunately, inguinal lymph node dissection is underused. Penile cancer treatment may have a major adverse impact on urinary and sexual function and on quality of life. Penile-sparing surgery and radiation therapies are available, and in selected patients offer good outcomes with acceptable rates of local recurrence. Penile-sparing surgery should be preferred when indicated. Follow-up with periodical controls is mandatory up to 5 years. However, risk of local, nodal and distant recurrence after 5 years was reported. Imaging is not routinely recommended during follow-up. Patients should be trained to self-examination during the follow-up.
2018
carcinoma; squamous cell; lymph node excision; organ sparing treatments; penile neoplasms
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
New insight in penile cancer / Marchioni, M.; Berardinelli, F.; De Nunzio, C.; Spiess, P.; Porpiglia, F.; Schips, L.; Cindolo, L.. - In: MINERVA UROLOGICA E NEFROLOGICA. - ISSN 0393-2249. - 70:6(2018), pp. 559-569. [10.23736/S0393-2249.18.03215-0]
File allegati a questo prodotto
File Dimensione Formato  
Marchioni_New-insight_2018.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 409.06 kB
Formato Adobe PDF
409.06 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1457462
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 17
social impact